Inventor · disambiguated record
Gang Zhou
Also filed as: ZHOU GANG
12 granted patents·10 pending applications·56 citations·filing 2008–2025
87Inventor score
Files withMERCK SHARP & DOHME9PGI DRUG DISCOVERY LLC4SHENZHEN IONOVA LIFE SCIENCE CO LTD2TING PAULINE C2CORETERRA THERAPEUTICS INC1
Top patents by PatentIndex Score
22 records- 0192US10011595B2Ethyldiamine orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Jul 3, 2018·7 cites·10 claims
- 0291US8637507B2Bicyclic compounds as inhibitors of diacylglycerol acyltransferaseZHOU GANG·Filed 2010·Granted Jan 28, 2014·33 cites·4 claims
- 0383US11555193B1Gene ANSB knockout mutant of citrobacter werkmanii and application thereofINST OF MICROBIOLOGY GUANGDONG ACADEMY OF SCIENCES GUANGDONG DETECTION CENTER OF MICROBIOLOGY·Filed 2022·Granted Jan 17, 2023·2 cites·4 claims
- 0483US10472347B2Aminopyrazine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2015·Granted Nov 12, 2019·5 cites·19 claims
- 0580US9938276B26,5-bicyclic octahydropyrrolopyridine orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Apr 10, 2018·2 cites·11 claims
- 0677US10138212B2Aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 27, 2018·2 cites·18 claims
- 0773US9676780B2Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2013·Granted Jun 13, 2017·2 cites·15 claims
- 0872US10519147B2Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2016·Granted Dec 31, 2019·1 cites·18 claims
- 0972US10221167B2Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·1 cites·46 claims
- 1064US2025129035A1Compounds for the treatment of a central nervous system disease or disorderPGI DRUG DISCOVERY LLC·Filed 2024·Application pending·0 cites
- 1163US8232274B2Pyridazinone derivatives useful as glucan synthase inhibitorsTING PAULINE C·Filed 2008·Granted Jul 31, 2012·1 cites·20 claims
- 1258US2025388558A1Compounds for the treatment of a central nervous system disease or disorderCORETERRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1356US12240860B2Heterobicyclic carboxylic acids and salts thereofSHENZHEN IONOVA LIFE SCIENCE CO LTD·Filed 2019·Granted Mar 4, 2025·0 cites·5 claims
- 1456US2025304546A1Compounds for the treatment of a central nervous system disease or disorderPGI DRUG DISCOVERY LLC·Filed 2025·Application pending·0 cites
- 1553US2023348373A1Deuterated derivatives of 6,8-bis(benzylsulfanyl)octanoic acidRAFAEL PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1651US2019233406A1HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELSMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 1751US2025236602A1Compounds for the treatment of a central nervous system disease or disorderPGI DRUG DISCOVERY LLC·Filed 2025·Application pending·0 cites
- 1847US2011224136A1Inhibitors of diacylglycerol acyltransferaseTING PAULINE C·Filed 2009·Application pending·0 cites
- 1946US10968210B2Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2017·Granted Apr 6, 2021·0 cites·19 claims
- 2046US2025243173A1Compounds for the treatment of a central nervous system disease or disorderPGI DRUG DISCOVERY LLC·Filed 2025·Application pending·0 cites
- 2137US2020352906A1Heterobicyclic Carboxylic Acids for Treating Cancer or Inflammatory DiseasesSHENZHEN IONOVA LIFE SCIENCE CO LTD·Filed 2019·Application pending·0 cites
- 2235US2014088124A1Imidazole derivativesDEVITA ROBERT J·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gang Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →